Literature DB >> 35930203

Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya.

Ingrid T Katz1,2,3,4,5, Kenneth Ngure6, Kevin Kamolloh7, Vallery Ogello7, Moses Okombo7, Nicholas B Thuo7, Esther Owino7, Lindsey E Garrison8, Yeonsoo S Lee9,10, Maria F Nardell9,11, Chiemelie Anyacheblu12,13, Elizabeth Bukusi7,14, Nelly Mugo7,15, Jared M Baeten15,16, Jessica E Haberer11,8.   

Abstract

Few studies have focused on understanding pre-exposure prophylaxis (PrEP) non-initiation among young, high-risk women in sub-Saharan Africa. This study aimed to qualitatively explore why young women in Kenya at high-risk for HIV chose not to enroll in a PrEP adherence trial. We performed 40 semi-structured interviews with young high-risk women assessing concerns about PrEP and/or study participation. We also assessed community-level factors influencing decision-making around PrEP through 10 focus groups involving peers, young men, caregivers, and community leaders. Our qualitative data reflect the complexity of navigating barriers preventing PrEP initiation in settings where taking PrEP may be perceived as immoral behavior. Framed within the context of risk perception, the decision to start PrEP may run counter to the potential risk of losing support from one's community. Our findings suggest that approaches addressing social norms, while de-medicalizing HIV prevention services, are needed to further increase PrEP uptake among young Kenyan women.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  HIV; Kenya; PrEP; Women

Year:  2022        PMID: 35930203     DOI: 10.1007/s10461-022-03748-9

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  50 in total

1.  HIV incidence rates in adolescent girls and young women in sub-Saharan Africa.

Authors:  Salim S Abdool Karim; Cheryl Baxter
Journal:  Lancet Glob Health       Date:  2019-11       Impact factor: 26.763

2.  Maximizing the Benefits of HIV Preexposure Prophylaxis.

Authors:  Susan P Buchbinder
Journal:  Top Antivir Med       Date:  2018-04

Review 3.  Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.

Authors:  Jessica E Haberer
Journal:  Curr Opin HIV AIDS       Date:  2016-01       Impact factor: 4.283

Review 4.  Forced sexual initiation, sexual intimate partner violence and HIV risk in women: a global review of the literature.

Authors:  Jamila K Stockman; Marguerite B Lucea; Jacquelyn C Campbell
Journal:  AIDS Behav       Date:  2013-03

5.  Rethinking HIV prevention to prepare for oral PrEP implementation for young African women.

Authors:  Connie L Celum; Sinead Delany-Moretlwe; Margaret McConnell; Heidi van Rooyen; Linda-Gail Bekker; Ann Kurth; Elizabeth Bukusi; Chris Desmond; Jennifer Morton; Jared M Baeten
Journal:  J Int AIDS Soc       Date:  2015-07-20       Impact factor: 5.396

6.  PrEP implementation research in Africa: what is new?

Authors:  Frances M Cowan; Sinead Delany-Moretlwe; Eduard J Sanders; Nelly R Mugo; Fernand A Guedou; Michel Alary; Luc Behanzin; Owen Mugurungi; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

7.  Defining the HIV pre-exposure prophylaxis care continuum.

Authors:  Amy S Nunn; Lauren Brinkley-Rubinstein; Catherine E Oldenburg; Kenneth H Mayer; Matthew Mimiaga; Rupa Patel; Philip A Chan
Journal:  AIDS       Date:  2017-03-13       Impact factor: 4.177

Review 8.  Sex Differences in HIV Infection.

Authors:  Eileen P Scully
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

9.  A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence?

Authors:  David Sidebottom; Anna Mia Ekström; Susanne Strömdahl
Journal:  BMC Infect Dis       Date:  2018-11-16       Impact factor: 3.090

10.  Gender inequality and HIV transmission: a global analysis.

Authors:  Eugene T Richardson; Sean E Collins; Tiffany Kung; James H Jones; Khai Hoan Tram; Victoria L Boggiano; Linda-Gail Bekker; Andrew R Zolopa
Journal:  J Int AIDS Soc       Date:  2014-06-27       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.